Plaintiff claimed that due to failure to timely deliver secondary to prolonged shoulder dystocia and cord compression, the infant suffered a hypoxic ischemic insult at delivery with concordant seizure activity, anoxia, and catastrophic brain injury.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More